-
341
-
342
Occurrence of severe cognitive impairment in elderly individuals with poor glycemic control Vs elderly individuals with good glycemic control or no DM: a case control study”
Published 2023-06-01“…Hypoglycemia has been associated with the increased risk of developing cognitive impairment. (4). There is lack of data from our community to support this. …”
Get full text
Article -
343
The Evaluation of Tau Deposition with [18F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease
Published 2021-01-01“…Therefore, this study’s aim was to perform a semiquantitative analysis of [18F]PI-2620 in individuals with normal cognition and patients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD). …”
Get full text
Article -
344
Compensatory increase in oxygen extraction fraction is associated with age-related cerebrovascular disease
Published 2025-01-01Subjects: Get full text
Article -
345
Glymphatic system clearance and Alzheimer’s disease risk: a CSF proteome-wide study
Published 2025-01-01Subjects: Get full text
Article -
346
Neuropsychiatric disorders in Wilson’s disease: literature review
Published 2023-10-01Subjects: Get full text
Article -
347
-
348
Risk prediction model of cognitive performance in older people with cardiovascular diseases: a study of the National Health and Nutrition Examination Survey database
Published 2025-01-01Subjects: “…cognitive impairment…”
Get full text
Article -
349
Pharmacophore-based virtual screening for identification of marine sponge bioactive compound inhibitors against Alzheimer's disease
Published 2025-06-01Subjects: Get full text
Article -
350
-
351
-
352
Untargeted urine metabolomics reveals dynamic metabolic differences and key biomarkers across different stages of Alzheimer’s disease
Published 2025-01-01Subjects: Get full text
Article -
353
The Role of Inflammation, Oxidative Stress, Neuronal Damage, and Endothelial Dysfunction in the Neuropathology of Cognitive Complications in Diabetes: A Moderation and Mediation An...
Published 2025-01-01Subjects: “…cognitive impairment…”
Get full text
Article -
354
Cognitive function differs across healthy lifestyle behavior profiles: a 10-year population-based prospective cohort study
Published 2025-02-01Subjects: Get full text
Article -
355
Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review
Published 2022-08-01“…Formal cognitive testing was documented in <30% of cognitively impaired patients diagnosed with MPS II before the age of 6 years. …”
Get full text
Article -
356
Neuroprotective Effect of Wharton’s Jelly-Derived Mesenchymal Stem Cell-Conditioned Medium (WJMSC-CM) on Diabetes-Associated Cognitive Impairment by Improving Oxidative Stress, Neuroinflammation, and Apoptosis
Published 2023-01-01“…According to strong evidence, diabetes mellitus increases the risk of cognitive impairment. Mesenchymal stem cells have been shown to be potential therapeutic agents for neurological disorders. …”
Get full text
Article -
357
BMAL1 ameliorates type 2 diabetes-induced cognitive impairment via AREG upregulation and PI3K/Akt/GSK-3β pathway activation
Published 2025-01-01Subjects: “…T2DM-associated cognitive impairment…”
Get full text
Article -
358
Diet Control and Swimming Exercise Ameliorate HFD-Induced Cognitive Impairment Related to the SIRT1-NF-κB/PGC-1α Pathways in ApoE-/- Mice
Published 2023-01-01“…High-fat diet- (HFD-) induced neuroinflammation may ultimately lead to an increased risk of cognitive impairment. Here, we evaluate the effects of diet control and swimming or both on the prevention of cognitive impairment by enhancing SIRT1 activity. …”
Get full text
Article -
359
Clinical Utility of an Alzheimer’s Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study
Published 2025-01-01“…<b>Objective</b>: The objective of this study was to assess clinical decision-making associated with the use of a multi-analyte blood biomarker (BBM) test among patients presenting with signs or symptoms of mild cognitive impairment or dementia. <b>Methods</b>: The Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey (NCT06025877) study evaluated the clinical utility of the PrecivityAD2™ blood test in a prospective, single cohort of 203 patients presenting with symptoms of Alzheimer’s disease (AD) or other causes of cognitive decline across 12 memory specialists. …”
Get full text
Article -
360